Investigating a key channel involved in heart function and drug development
Cardiovascular drug target, TRPV2
This study is looking at a special channel in your heart called TRPV2 to see how it reacts to pressure and certain fats, which could help scientists create better medicines for heart problems that don’t have good treatments right now.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11075885 on NIH RePORTER |
What this research studies
This research focuses on the TRPV2 cation channel, which plays a crucial role in the cardiovascular system's development and function. The project aims to understand how TRPV2 is regulated by mechanical stress and specific lipids, which could lead to the creation of more effective drugs targeting this channel. By using advanced techniques like patch-clamp electrophysiology and Ca2+-indicator dyes, researchers will explore how TRPV2 responds to various stimuli and how this knowledge can improve drug specificity and potency. The ultimate goal is to develop better treatments for cardiovascular conditions that currently lack effective therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cardiovascular conditions who may benefit from new therapeutic options targeting the TRPV2 channel.
Not a fit: Patients with non-cardiovascular conditions or those who do not respond to current cardiovascular treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted drugs for treating cardiovascular diseases.
How similar studies have performed: Previous studies have shown promising results in targeting TRPV2 for cardiovascular treatment, indicating potential for success in this novel approach.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Wensel, Theodore G — Baylor College of Medicine
- Study coordinator: Wensel, Theodore G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.